Self-catalytic antibodies for the efficient production of antibody-drug conjugates (Self-ADC)

• Forschungsstelle: INNOSUISSE
• Projektnummer: 125.905 IP-LS
• Projekttitel Englisch: Self-catalytic antibodies for the efficient production of antibody-drug conjugates (Self-ADC)

Schlüsselwörter (Englisch)

Life sciences, Biotechnology and processing

Abstract (Englisch)

Self-ADC proposes a novel approach to antibody-drug conjugate production. It simplifies antibody bioconjugation without complex chemistry or costly enzymes. Multidisciplinary in essence, Self-ADC combines protein engineering with antibody production, synthetic chemistry, and biomolecular analytics.